Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)
AH Norooznezhad, K Mansouri - Microvascular research, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been led to a pandemic emergency. So far …
syndrome coronavirus 2 (SARS-CoV-2) has been led to a pandemic emergency. So far …
Vascular dysfunction and its cardiovascular consequences during and after COVID-19 infection: a narrative review
M Kar - Vascular Health and Risk Management, 2022 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory coronavirus 2 (SARS-CoV2) has brought out changes in our daily life and has …
respiratory coronavirus 2 (SARS-CoV2) has brought out changes in our daily life and has …
The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo
L Beltrán-Camacho, S Eslava-Alcón, M Rojas-Torres… - Molecular …, 2022 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already
caused 6 million deaths worldwide. While asymptomatic individuals are responsible of many …
caused 6 million deaths worldwide. While asymptomatic individuals are responsible of many …
The impact of the hypoxia‐VEGF‐vascular permeability on COVID‐19‐infected patients
Y Cao - Exploration, 2021 - Wiley Online Library
Effective treatment of patients with severe COVID‐19 to reduce mortality remains one of the
most challenging medical issues in controlling unpredictable emergencies caused by the …
most challenging medical issues in controlling unpredictable emergencies caused by the …
Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer
The dramatic impact of the COVID-19 pandemic has resulted in an “all hands on deck”
approach to find new therapies to improve outcomes in this disease. In addition to causing …
approach to find new therapies to improve outcomes in this disease. In addition to causing …
Looking beyond pulmonary disease in COVID-19: a lesson from patients with cystic fibrosis
S Manti, GF Parisi, M Papale, E Mule, D Aloisio… - Medical …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused more than 52.775. 271 million
confirmed cases, 1.293. 106 deaths, globally, and afflicted 208 countries, areas, or …
confirmed cases, 1.293. 106 deaths, globally, and afflicted 208 countries, areas, or …
[PDF][PDF] Pharmacological protection of vascular endothelium in acute COVID-19.
K Bednarz, A Borek, F Drzymala, K Rachwal… - Journal of Physiology …, 2022 - jpp.krakow.pl
Since the beginning of the COVID-19 pandemic, there has been an urgent need to find
effective treatment. It is widely known that virus attacks and damages mostly the lungs, but …
effective treatment. It is widely known that virus attacks and damages mostly the lungs, but …
Pathophysiological aspects of COVID-19-associated vasculopathic diseases
T Greistorfer, P Jud - Thrombosis and Haemostasis, 2023 - thieme-connect.com
Since the beginning of coronavirus disease 2019 (COVID-19) pandemic, numerous data
reported potential effects on the cardiovascular system due to infection by severe acute …
reported potential effects on the cardiovascular system due to infection by severe acute …
Endothelial dysfunction in COVID-19: lessons learned from coronaviruses
E Gavriilaki, P Anyfanti, M Gavriilaki, A Lazaridis… - Current hypertension …, 2020 - Springer
Abstract Purpose of Review To review current literature on endothelial dysfunction with
previous coronaviruses, and present available data on the role of endothelial dysfunction in …
previous coronaviruses, and present available data on the role of endothelial dysfunction in …